IDH1 and astrocytoma (excluding glioblastoma): The survival analysis showed TERTp mutation as a prognostic factor for OS in the group of all IDH-wild-type astrocytomas and IDH-wild-type DAs, and the diagnosis of “astrocytoma, grade 4” with EGFR amplification was significant only in all IDH-wild-type astrocytomas.